The San Francisco Health Commission convened on July 4, 2025, to discuss several key agenda items, with a notable focus on honoring Dr. Amanda Sue Carlisle for her extensive contributions to the public health community.
The meeting commenced with a resolution presented by Dr. Susan Ehrlich, CEO of Zuckerberg San Francisco General Hospital, recognizing Dr. Carlisle's remarkable career. Dr. Ehrlich detailed Dr. Carlisle's impressive qualifications, including her roles as associate dean at the University of California School of Medicine and Chief of Anesthesia at San Francisco General Hospital. Dr. Carlisle has been instrumental in enhancing collaboration between UCSF and the hospital, significantly improving patient care.
Dr. Ehrlich highlighted Dr. Carlisle's leadership in the planning and approval processes for the new UCSF Research and Academic Building, set to be completed in 2023. Dr. Carlisle's academic credentials were also noted, including her MS and PhD from Tulane University and her medical degree from the University of Pennsylvania.
Throughout her career, Dr. Carlisle has received numerous accolades, including the Lloyd Holly Smith Award for Service and the UCSF Chancellor's Award for Advancement of Women. She is recognized for her commitment to mentoring women and underrepresented minorities in the medical field, advocating for their advancement into leadership roles.
The resolution concluded with a formal recognition of Dr. Carlisle's outstanding service and leadership within the San Francisco public health community, underscoring her significant impact on healthcare in the region. The Health Commission adopted the resolution unanimously, reflecting a strong consensus on Dr. Carlisle's contributions.
In summary, the meeting underscored the importance of recognizing exemplary figures in public health and the ongoing commitment to fostering diversity and leadership within the medical community.